Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation

No abstract is available for this paper.

• Publication year

  1990

• Venue

  European Journal of Immunology

• Publication date

  1990-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830200118PMID 1689659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of human T lymphocytes by bryostatin.

  1988cited by this paper
• A new antigen identified by the monoclonal antibody UCHB1 delivers a costimulatory signal to a subset of human B cells

  1988cited by this paper
• Phosphorylation of lamin B at the nuclear membrane by activated protein kinase C.

  1988cited by this paper
• Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells.

  1988cited by this paper
• The role of protein phosphorylation in the control of cell growth and differentiation.

  1988cited by this paper
• Double and triple staining methods for studying the proliferative activity of human B and T lymphoid cells.

  1988cited by this paper
• Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture.

  1988cited by this paper
• Immunomodulating properties of a novel series of protein kinase C activators. The bryostatins.

  1988cited by this paper
• Differential expression of MHC class II antigens in chronic B-cell disorders.

  1988cited by this paper
• Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations.

  1988cited by this paper
• Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.

  1988cited by this paper
• An assessment of phosphoinositide hydrolysis in antigenic signal transduction in lymphocytes.

  1988cited by this paper
• Comparative effects of polymyxin B, phorbol ester and bryostatin on protein phosphorylation, protein kinase C translocation, phospholipid metabolism and differentiation of HL60 cells.

  1987cited by this paper
• Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.

  1987cited by this paper
• B7, a B-cell-restricted antigen that identifies preactivated B cells.

  1987cited by this paper
• Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells.

  1987cited by this paper
• The cyclosporins inhibit lymphocyte activation at more than one site.

  1987cited by this paper
• Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.

  1987cited by this paper
• Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.

  1987cited by this paper
• Regulation of B-lymphocyte activation, proliferation, and immunoglobulin secretion.

  1986cited by this paper
• Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.

  1986cited by this paper
• Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways.

  1986cited by this paper
• Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

  1986cited by this paper
• B cell growth factor activity of interferon-gamma. Recombinant human interferon-gamma promotes proliferation of anti-mu-activated human B lymphocytes.

  1986cited by this paper
• Signal transduction and intracellular events in T-lymphocyte activation.

  1986cited by this paper
• Studies and perspectives of protein kinase C.

  1986cited by this paper
• Cloning and expression of multiple protein kinase C cDNAs.

  1986cited by this paper
• Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells.

  1986cited by this paper
• Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.

  1986cited by this paper
• Synergistic action of A23187 and phorbol ester on human B cell activation.

  1985cited by this paper
• Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.

  1985cited by this paper
• Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters.

  1985cited by this paper
• B lymphocyte receptors and polyphosphoinositide degradation.

  1985cited by this paper
• A Combination of Calcium Ionophore and 12‐O‐Tetradecanoyl‐Phorbol‐13‐Acetate (TPA) Stimulates the Growth of Purified Resting B Cells

  1985cited by this paper
• The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin.

  1985cited by this paper
• Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.

  1985cited by this paper
• The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.

  1985cited by this paper
• Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester

  1985cited by this paper
• Factors affecting B-cell growth and differentiation.

  1985cited by this paper
• Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor.

  1985cited by this paper
• Human B Cell Activation, Proliferation and Differentiation

  1984cited by this paper
• Differential expression of cell activation markers after stimulation of resting human B lymphocytes.

  1984cited by this paper
• B cell activation: three steps and their variations.

  1984cited by this paper
• Expression of interleukin 2 receptors on activated human B cells

  1984cited by this paper
• The role of protein kinase C in cell surface signal transduction and tumour promotion

  1984cited by this paper
• The role of the transferrin receptor in human B lymphocyte activation.

  1984cited by this paper
• Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

  1984cited by this paper
• Frequency of B lymphocytes responsive to anti-immunoglobulin

  1982cited by this paper
• Isolation and structure of bryostatin 1

  1982cited by this paper
• Antineoplastic Components of Marine Animals

  1970cited by this paper

• The antimicrobial and immunomodulatory effects of Ionophores for the treatment of human infection.

  2021cites this paper
• The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication

  2016cites this paper
• The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical development.

  2012cites this paper
• Posttranscriptional Control of IFN-Subunits in Monocytic Cells : Transcriptional Receptor γ Differentially Regulates IFN-The Antineoplastic Agent Bryostatin-1

  2006cites this paper
• The antineoplastic agent bryostatin-1 differentially regulates IFN-gamma receptor subunits in monocytic cells: transcriptional and posttranscriptional control of IFN-gamma R2.

  2006cites this paper
• The Antineoplastic Agent Bryostatin-1 Differentially Regulates IFN-γ Receptor Subunits in Monocytic Cells: Transcriptional and Posttranscriptional Control of IFN-γR21

  2006cites this paper
• Enhanced Expression of CD20 in Human Tumor B Cells Is Controlled through ERK-Dependent Mechanisms

  2005cites this paper
• Enhanced Expression of CD20 in Human

  2005cites this paper
• CHAPTER 12 – BIOSYNTHETIC PRODUCTS FOR ANTICANCER DRUG DESIGN AND TREATMENT: THE BRYOSTATINS

  2002cites this paper
• Bryostatin-1 and IL-2 Synergize to Induce IFN-γ Expression in Human Peripheral Blood T Cells: Implications for Cancer Immunotherapy1

  2001cites this paper
• Immunotherapy Blood T Cells : Implications for Cancer Expression in Human Peripheral γ IFN-Bryostatin-1 and IL-2 Synergize to Induce Aguero and

  2001cites this paper
• Compatibility and stability of bryostatin 1 in infusion devices

  1998cites this paper
• A phase II study of bryostatin 1 in metastatic malignant melanoma.

  1998cites this paper
• In vitro culture of Taenia crassiceps larval cells and cyst regeneration after injection into mice.

  1997cites this paper
• The antineoplastic agent bryostatin-1 induces proinflammatory cytokine production in human monocytes: synergy with interleukin-2 and modulation of interleukin-2Rgamma chain expression.

  1997cites this paper
• Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro.

  1996cites this paper
• Theory of the Origin, Function, and Evolution Secondary Metabolites*

  1995cites this paper
• The antineoplastic bryostatins affect human basophils and mast cells differently.

  1995cites this paper
• Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection

  1995cites this paper
• Erythropoietin modulation of intracellular calcium: a role for tyrosine phosphorylation.

  1994cites this paper
• Protein kinase C activation without membrane contact in platelets stimulated by bryostatin.

  1993cites this paper
• Antitumor and Cytotoxic Compounds from Marine Organisms

  1993cites this paper
• A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

  1993cites this paper
• Evidence for programmed cell death of self‐reactive γδ T cell receptor‐positive thymocytes

  1993cites this paper
• B‐cell chronic lymphocytic leukaemia cells express and release transforming growth factor‐β

  1992cites this paper
• The bryostatins.

  1991cites this paper
• Calcium-stimulated parathyroid hormone-like protein secretion: potentiation through a protein kinase-C pathway.

  1991cites this paper